AstraZeneca hit by drug rejection
233492
Shares in drug giant AstraZeneca fall after a US medical panel recommends that regulators reject its new drug Exanta.
100059
Twenty-nine patients who took AstraZeneca Plc&#39;s AZN.L AZN.N anti-cholesterol drug Crestor have developed kidney damage, a US consumer group said on Friday as it called again for a ban on the medicine.
65596
US regulators say recent newspaper ads for AstraZeneca&#39;s Crestor, a cholesterol-lowering drug, are false or misleading. An unusual letter from the Food and Drug Administration, sent Wednesday, dismissed as
691286
Drug maker AstraZeneca PLC said Friday that the Food and Drug Administration did not approve its orally taken blood thinner Exanta.
373448
Lawmakers called for hearings to investigate the rejection of the Dendreon Corporationâs experimental prostate cancer drug.
527141
LONDON - Drug manufacturer AstraZeneca PLC announced Friday that trials of its new lung cancer drug found it didn&#39;t help patients live longer.
646800
Gaithersburg-based GenVec has run into a problem with its top drug candidate, and investors have had an adverse reaction. GenVec says the US Food and Drug Administration has requested that clinical trials
600129
Anglo-Swedish drugs giant AstraZeneca and British peer GlaxoSmithKline said Wednesday they had been approached by EU regulators as part of an antitrust probe into the pharmaceutical sector.
579894
Twenty-nine patients who took AstraZeneca Plc's  cholesterol drug Crestor have developed kidney damage, a U.S. consumer group said on Friday as it called again for a ban on the medicine.
477368
BETHESDA, Md.  - A U.S. panel of medical experts  recommended on Friday that U.S. regulators reject AstraZeneca's  AZN.L AZN.N application to sell its anti-clotting drug  Exanta.
37345
Teva's lupus drug fails to meet its primary endpoint in its phase 2 trial.
117545
AstraZeneca Plc AZN.L AZN.N on  Friday said U.S. regulators did not approve its anti-clotting  drug Exanta.
52228
Drug maker AstraZeneca Plc  AZN.L on Thursday said it has sued generic drug maker  KV Pharmaceutical Co KVa.N over one of its branded high blood  pressure medications.
479311
Shares in AstraZeneca Plc fell as much  as 10 percent on Friday after regulators in the United States  and Europe raised safety concerns about the Anglo-Swedish drug  maker's anti-cholesterol treatment Crestor.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
15055
AstraZeneca Plc (AZN) on Friday said US regulators did not approve its anti-clotting drug Exanta. The US Food and Drug Administration followed the advice of an advisory panel, which last
226836
AstraZeneca Plc suffered its third setback in two months on Friday as lung cancer drug Iressa failed to help patients live longer